{"id":"https://openalex.org/W4410404696","doi":"https://doi.org/10.1002/ddr.70084","title":"Augmenting the Anti\u2010Leukemic Activity of the BCL\u20102 Inhibitor Venetoclax Through Its Transformation Into Polypharmacologic Dual BCL\u20102/HDAC1 and Dual BCL\u20102/HDAC6 Inhibitors","display_name":"Augmenting the Anti\u2010Leukemic Activity of the BCL\u20102 Inhibitor Venetoclax Through Its Transformation Into Polypharmacologic Dual BCL\u20102/HDAC1 and Dual BCL\u20102/HDAC6 Inhibitors","alternate_titles":[],"publication_year":2025,"publication_date":"2025-05-01","ids":{"openalex":"https://openalex.org/W4410404696","doi":"https://doi.org/10.1002/ddr.70084","pmid":"https://pubmed.ncbi.nlm.nih.gov/40370107","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12079163"},"language":"en","primary_location":{"id":"doi:10.1002/ddr.70084","doi":"https://doi.org/10.1002/ddr.70084","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ddr.70084","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ddr.70084","source":{"id":"https://openalex.org/S26306840","display_name":"Drug Development Research","issn_l":"0272-4391","issn":["0272-4391","1098-2299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4410404696"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ddr.70084","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041090967","display_name":"Alexandria M. Chan","orcid":"https://orcid.org/0000-0001-6196-3036","observed_orcids":["https://orcid.org/0000-0001-6196-3036"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexandria M. Chan","raw_affiliation_strings":["Department of Pharmaceutical Sciences University of Maryland School of Pharmacy Baltimore Maryland USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences University of Maryland School of Pharmacy Baltimore Maryland USA","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023614055","display_name":"Christian L. Eberly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christian Eberly","raw_affiliation_strings":["Center for Stem Cell Biology & Regenerative Medicine, Department of Pediatrics University of Maryland School of Medicine Baltimore Maryland USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Stem Cell Biology & Regenerative Medicine, Department of Pediatrics University of Maryland School of Medicine Baltimore Maryland USA","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065774976","display_name":"Brandon Drennen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brandon Drennen","raw_affiliation_strings":["Department of Pharmaceutical Sciences University of Maryland School of Pharmacy Baltimore Maryland USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences University of Maryland School of Pharmacy Baltimore Maryland USA","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079825892","display_name":"Christopher C. Goodis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher C. Goodis","raw_affiliation_strings":["Department of Pharmaceutical Sciences University of Maryland School of Pharmacy Baltimore Maryland USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences University of Maryland School of Pharmacy Baltimore Maryland USA","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117557555","display_name":"Zoe Wuyts","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Zoe Wuyts","raw_affiliation_strings":["School of Chemistry Cardiff University Main Building Cardiff UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Chemistry Cardiff University Main Building Cardiff UK","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047214928","display_name":"Curt I. Civin","orcid":"https://orcid.org/0000-0002-9555-4895","observed_orcids":["https://orcid.org/0000-0002-9555-4895"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]},{"id":"https://openalex.org/I4390039317","display_name":"University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center","ror":"https://ror.org/01vft3j45","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I14285509","https://openalex.org/I4390039317"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Curt I. Civin","raw_affiliation_strings":["Center for Stem Cell Biology & Regenerative Medicine, Departments of Pediatrics and Pharmacology, Physiology & Drug Development University of Maryland School of Medicine Baltimore Maryland USA","University of Maryland Greenebaum Cancer Center Baltimore Maryland USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Stem Cell Biology & Regenerative Medicine, Departments of Pediatrics and Pharmacology, Physiology & Drug Development University of Maryland School of Medicine Baltimore Maryland USA","institution_ids":["https://openalex.org/I126744593"]},{"raw_affiliation_string":"University of Maryland Greenebaum Cancer Center Baltimore Maryland USA","institution_ids":["https://openalex.org/I4390039317"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033946508","display_name":"Steven Fletcher","orcid":"https://orcid.org/0000-0002-4429-8334","observed_orcids":["https://orcid.org/0000-0002-4429-8334"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]},{"id":"https://openalex.org/I4390039317","display_name":"University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center","ror":"https://ror.org/01vft3j45","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I14285509","https://openalex.org/I4390039317"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Steven Fletcher","raw_affiliation_strings":["Department of Pharmaceutical Sciences University of Maryland School of Pharmacy Baltimore Maryland USA","University of Maryland Greenebaum Cancer Center Baltimore Maryland USA"],"raw_orcid":"https://orcid.org/0000-0002-4429-8334","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences University of Maryland School of Pharmacy Baltimore Maryland USA","institution_ids":["https://openalex.org/I126744593"]},{"raw_affiliation_string":"University of Maryland Greenebaum Cancer Center Baltimore Maryland USA","institution_ids":["https://openalex.org/I4390039317"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5033946508","https://openalex.org/A5047214928"],"corresponding_institution_ids":["https://openalex.org/I126744593","https://openalex.org/I4390039317"],"apc_list":{"value":3980,"currency":"USD","value_usd":3980},"apc_paid":{"value":3980,"currency":"USD","value_usd":3980},"fwci":1.0784,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.71111445,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":97},"biblio":{"volume":"86","issue":"3","first_page":"e70084","last_page":"e70084"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.9154999852180481,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.9154999852180481,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.04800000041723251,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.00839999970048666,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":1.0},{"id":"https://openalex.org/keywords/bcl2-inhibitors","display_name":"BCL-2 inhibitor","score":0.9210000038146973},{"id":"https://openalex.org/keywords/hdac1-inhibitors","display_name":"HDAC1 inhibitors","score":0.7760000228881836},{"id":"https://openalex.org/keywords/hdac6-inhibitors","display_name":"HDAC6 inhibitors","score":1.0},{"id":"https://openalex.org/keywords/polypharmacology","display_name":"polypharmacology","score":0.890999972820282},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.8349999785423279},{"id":"https://openalex.org/keywords/mv4-11-cells","display_name":"MV4-11 cells","score":0.7770000100135803},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8759999871253967},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.6069999933242798},{"id":"https://openalex.org/keywords/bcl-2-overexpression","display_name":"Bcl-2 overexpression","score":0.703000009059906}],"concepts":[{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.9336323738098145},{"id":"https://openalex.org/C85240754","wikidata":"https://www.wikidata.org/wiki/Q14914420","display_name":"HDAC1","level":5,"score":0.5852124691009521},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5735895037651062},{"id":"https://openalex.org/C23681527","wikidata":"https://www.wikidata.org/wiki/Q18034953","display_name":"HDAC6","level":5,"score":0.5725376605987549},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5410986542701721},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4694112539291382},{"id":"https://openalex.org/C56173144","wikidata":"https://www.wikidata.org/wiki/Q1539893","display_name":"Pharmacophore","level":2,"score":0.4245634377002716},{"id":"https://openalex.org/C2776202225","wikidata":"https://www.wikidata.org/wiki/Q3569101","display_name":"Histone deacetylase inhibitor","level":5,"score":0.4210507571697235},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.3339046239852905},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3109933137893677},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2803725302219391},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.27694275975227356},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.26656216382980347},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.23889842629432678},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.235458105802536},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1628943383693695},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000073864","descriptor_name":"Histone Deacetylase 6","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000073864","descriptor_name":"Histone Deacetylase 6","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056284","descriptor_name":"Histone Deacetylase 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D056284","descriptor_name":"Histone Deacetylase 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1002/ddr.70084","doi":"https://doi.org/10.1002/ddr.70084","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ddr.70084","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ddr.70084","source":{"id":"https://openalex.org/S26306840","display_name":"Drug Development Research","issn_l":"0272-4391","issn":["0272-4391","1098-2299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development Research","raw_type":"journal-article"},{"id":"pmid:40370107","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40370107","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug development research","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12079163","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12079163/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Dev Res","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1002/ddr.70084","doi":"https://doi.org/10.1002/ddr.70084","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ddr.70084","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ddr.70084","source":{"id":"https://openalex.org/S26306840","display_name":"Drug Development Research","issn_l":"0272-4391","issn":["0272-4391","1098-2299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9074000120162964,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6403338174","display_name":"Synthetic Strategies to Restore the Efficacy of Venetoclax in Acute Myeloid Leukemia","funder_award_id":"R21CA256314","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6595812871","display_name":"Graduate Training at The Chemistry Biology Interface","funder_award_id":"T32GM066706","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4410404696.pdf","grobid_xml":"https://content.openalex.org/works/W4410404696.grobid-xml"},"referenced_works_count":48,"referenced_works":["https://openalex.org/W1851613051","https://openalex.org/W2042828682","https://openalex.org/W2063078660","https://openalex.org/W2088883749","https://openalex.org/W2091562724","https://openalex.org/W2113703332","https://openalex.org/W2117551758","https://openalex.org/W2172242534","https://openalex.org/W2193348648","https://openalex.org/W2255447708","https://openalex.org/W2277797998","https://openalex.org/W2278828177","https://openalex.org/W2298114970","https://openalex.org/W2340621314","https://openalex.org/W2402506318","https://openalex.org/W2520367679","https://openalex.org/W2536781322","https://openalex.org/W2732707479","https://openalex.org/W2761708088","https://openalex.org/W2766023905","https://openalex.org/W2773548225","https://openalex.org/W2884740260","https://openalex.org/W2905930033","https://openalex.org/W2908910315","https://openalex.org/W2926677816","https://openalex.org/W2978352563","https://openalex.org/W2998271258","https://openalex.org/W3011469361","https://openalex.org/W3037213932","https://openalex.org/W3039236515","https://openalex.org/W3110878615","https://openalex.org/W3119240638","https://openalex.org/W3126561970","https://openalex.org/W3164860814","https://openalex.org/W3186606314","https://openalex.org/W3206226732","https://openalex.org/W4200474412","https://openalex.org/W4212787271","https://openalex.org/W4221065122","https://openalex.org/W4307231141","https://openalex.org/W4313045364","https://openalex.org/W4386839055","https://openalex.org/W4387692809","https://openalex.org/W4389221110","https://openalex.org/W4392882101","https://openalex.org/W4403474684","https://openalex.org/W4403500490","https://openalex.org/W4405668626"],"related_works":["https://openalex.org/W4306320446","https://openalex.org/W7203588177","https://openalex.org/W4400786152","https://openalex.org/W3012377581","https://openalex.org/W2761708088","https://openalex.org/W4409191207","https://openalex.org/W4367553358","https://openalex.org/W2594814896","https://openalex.org/W7125530204","https://openalex.org/W4389219024"],"abstract_inverted_index":{"Motivated":[0],"by":[1,33],"the":[2,11,26,30,54,75,97,131,152],"anti-leukemic":[3,27],"synergy":[4],"between":[5],"histone":[6],"deacetylase":[7],"(HDAC)":[8],"inhibitors":[9],"and":[10,61,91,104,146],"FDA-approved":[12],"BCL-2":[13,56],"inhibitor":[14,38],"venetoclax,":[15,84],"coupled":[16],"with":[17,68],"our":[18,87],"interests":[19],"in":[20],"polypharmacology,":[21],"we":[22],"sought":[23],"to":[24,71,82,110,128,142],"bolster":[25],"efficacy":[28],"of":[29,44,59,86,120,154],"clinical":[31],"drug":[32],"grafting":[34],"HDAC1-selective":[35],"or":[36,66,133],"HDAC6-selective":[37],"motifs":[39],"onto":[40],"a":[41,158],"solvent-accessible":[42],"domain":[43],"venetoclax.":[45,163],"We":[46],"discovered":[47],"multiple":[48],"polypharmacological":[49],"agents":[50],"that":[51],"both":[52],"retained":[53],"potent":[55],"inhibitory":[57],"activity":[58],"venetoclax":[60],"effectively":[62],"inhibited":[63],"either":[64],"HDAC1":[65,132],"HDAC6":[67,134],"excellent":[69],"(up":[70],"80-fold)":[72],"selectivities":[73,138],"for":[74,122],"desired":[76],"HDAC":[77],"isoform.":[78],"In":[79],"addition,":[80],"relative":[81],"parental":[83],"two":[85],"lead":[88],"compounds,":[89],"BD-4-213":[90],"AMC-4-154,":[92],"exhibited":[93],"superior":[94],"activities":[95],"against":[96],"acute":[98],"myeloid":[99],"leukemia":[100],"cell":[101,107],"line":[102,108],"MV4;11":[103,106],"an":[105,117],"engineered":[109],"overexpress":[111],"BCL-2.":[112],"Annexin-V":[113],"assay":[114],"results":[115],"confirmed":[116],"on-target":[118],"mechanism":[119],"apoptosis":[121],"these":[123],"novel":[124],"chimeric":[125],"molecules.":[126],"Efforts":[127],"further":[129],"boost":[130],"binding":[135],"affinities":[136],"and/or":[137],"proved":[139],"unsuccessful":[140],"due":[141],"synthetic":[143],"chemistry":[144],"challenges":[145],"solubility":[147],"problems,":[148],"which":[149],"may":[150],"underscore":[151],"difficulties":[153],"polypharmacology":[155],"approaches":[156],"involving":[157],"large":[159],"inhibitor,":[160],"such":[161],"as":[162]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4410404696","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2025-05-16T00:00:00"}
